Allahabad High Court Codeine Syrup Bail: Masterminds Denied, Minor Players Granted

• The Allahabad High Court rejected bail for 17 alleged 'masterminds' in codeine syrup diversion cases but granted bail to drivers and small retailers.
• The court ruled that the NDPS Act applies when codeine-based cough syrup is diverted for intoxication, but not for legitimate medical purposes.
• Bail was denied to principal accused involved in fake firms, forged invoices, and large-scale diversion of hundreds of thousands of syrup bottles.
• Drivers were granted bail due to a lack of evidence proving their knowledge of the illicit nature or contents of the sealed consignments they transported.
• The judgment clarifies the importance of establishing criminal intent (*mens rea*) in NDPS cases, particularly for individuals with limited roles.

The court ruled that the NDPS Act applies when codeine-based cough syrup is diverted for intoxication, but not for legitimate medical purposes.

The Allahabad High Court recently issued a significant ruling concerning bail applications in cases involving the alleged illegal storage, transportation, and sale of codeine-based cough syrups. In a common judgment delivered on September 1, 2026, Justice Arun Kumar Singh Deshwal addressed 77 bail applications, drawing a clear distinction between individuals accused of orchestrating large-scale diversion and those with more limited, often unwitting, roles.

The court denied bail to 17 individuals identified as alleged 'masterminds' or principal operators in the illicit trade. These individuals were implicated in the systematic diversion of codeine syrup for non-medical purposes, often involving sophisticated schemes. Conversely, the court granted bail to truck drivers, helpers, and small retailers, finding insufficient evidence to suggest their knowing participation in the diversion of these medicines for intoxication.

A central tenet of the court's decision revolved around the application of the Narcotic Drugs and Psychotropic Substances (NDPS) Act. The bench clarified that codeine-based cough syrup does not fall under the purview of the NDPS Act when handled for legitimate medical purposes. However, this statutory protection is forfeited when the medicine is diverted, stocked, or sold with the intent of intoxication, thereby triggering the stringent provisions of the Act.

The prosecution's case against the principal accused highlighted allegations of creating fake firms, forging invoices, and manipulating e-way bills to facilitate the diversion of substantial quantities of cough syrup outside the regulated pharmaceutical supply chain. For instance, Bhola Prasad, proprietor of Saili Traders, faced accusations that two firms in Sonbhadra purchased approximately 7.53 lakh bottles of New Phensedyl from his company between April 2024 and August 2025. Evidence also suggested large consignments were moved through fraudulent paper transactions, with e-way bills for 3.39 lakh bottles from Saili Traders listing unsuitable or non-existent vehicles like e-rickshaws, ambulances, or government vehicles, with some batches later recovered in distant states like Tripura and West Bengal. Other key accused, such as Divesh Jaiswal, were found prima facie involved in establishing fake firms and arranging forged invoices, while Ankush Singh and Abhinav Kumar Yadav were implicated in the diversion of 5.21 lakh and 2,25,999 bottles of New Phensedyl, respectively.

Crucially, the Allahabad High Court codeine syrup bail ruling underscored the importance of establishing criminal intent, or *mens rea*, particularly for individuals with peripheral involvement. The court drew a sharp distinction between the principal operators and those whose roles were limited to transporting or handling sealed consignments, emphasizing that mere possession or transportation without knowledge of the illicit purpose does not automatically warrant detention under the NDPS Act.

This principle was evident in the cases of several drivers who were granted bail. Rehan Alam Raeen, for example, was allegedly driving a car containing 200 bottles of cough syrup in sealed cardboard boxes. The court noted the absence of material demonstrating his knowledge of the cartons' contents or that the medicine was being transported for a non-medical purpose, alongside his lack of criminal history and the filing of the chargesheet. Similarly, truck driver Sushil Yadav received bail in a case involving 15,300 bottles of Eskuf, packed in bags and cartons, with no evidence suggesting he knew their contents. Dharmendra Kumar Singh, another truck driver, was also granted bail for a consignment of 41,100 bottles, as the court found no material to indicate his knowledge of the consignment's nature, further considering his clean criminal record and the completion of the chargesheet.

This judgment provides vital clarity on the evidentiary requirements for establishing culpability in NDPS cases, particularly concerning codeine cough syrup diversion India. It sets a precedent that mere involvement in the logistics of a consignment, without proof of knowledge or intent to divert for intoxication, may not be sufficient to deny bail, especially for individuals like drivers or helpers. The ruling effectively differentiates between those who knowingly participate in drug trafficking India and those who might be unwitting carriers.

For defense lawyers, the decision strengthens arguments for bail for drug couriers India who can demonstrate a lack of *mens rea*. For prosecutors, it highlights the necessity of presenting concrete evidence of knowledge and intent, particularly when dealing with individuals in supporting roles. The court's emphasis on distinguishing legitimate medical purpose NDPS from illicit diversion reinforces the need for thorough investigation into the entire supply chain to identify the true orchestrators of such schemes, while protecting those who may be inadvertently caught in the crossfire.

This ruling clarifies the *mens rea* requirement in NDPS cases involving codeine syrup diversion, providing a crucial precedent for defence lawyers representing individuals with limited roles (e.g., drivers) and guiding prosecutors on the evidence needed to establish knowledge and intent for different levels of accused. Compliance officers in pharmaceutical distribution should review their supply chain controls to mitigate diversion risks and protect employees from unwitting involvement.

Source: Original reporting via Live Law